Bavarian Nordic eyes more U.S. government contracts after new vaccine order

COPENHAGEN (Reuters) - Danish drug maker Bavarian Nordic expects to win further U.S. contracts for its smallpox vaccine after it secured a key government order, the company said on Thursday.